INTRA-LABORATORIES LTD

Company Registration Number:
10704591 (England and Wales)

Unaudited abridged accounts for the year ended 15 April 2025

Period of accounts

Start date: 16 April 2024

End date: 15 April 2025

INTRA-LABORATORIES LTD

Contents of the Financial Statements

for the Period Ended 15 April 2025

Balance sheet
Notes

INTRA-LABORATORIES LTD

Balance sheet

As at 15 April 2025


Notes
2025
2024


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets: 3 19,210 20,286
Tangible assets: 4 3,063 3,283
Investments:   0 0
Total fixed assets: 22,273 23,569
Current assets
Stocks: 61,739 65,059
Debtors:   81,776 81,844
Cash at bank and in hand: 15,283 22,094
Investments:   0 0
Total current assets: 158,798 168,997
Creditors: amounts falling due within one year:   (83,373) (94,802)
Net current assets (liabilities): 75,425 74,195
Total assets less current liabilities: 97,698 97,764
Creditors: amounts falling due after more than one year:   (96,656) (96,656)
Provision for liabilities: 0 0
Total net assets (liabilities): 1,042 1,108
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 942 1,008
Shareholders funds: 1,042 1,108

The notes form part of these financial statements

INTRA-LABORATORIES LTD

Balance sheet statements

For the year ending 15 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 12 January 2026
and signed on behalf of the board by:

Name: Daniel Mckintosh
Status: Director

The notes form part of these financial statements

INTRA-LABORATORIES LTD

Notes to the Financial Statements

for the Period Ended 15 April 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

INTRA-LABORATORIES LTD

Notes to the Financial Statements

for the Period Ended 15 April 2025

2. Employees

2025 2024
Average number of employees during the period 8 9

INTRA-LABORATORIES LTD

Notes to the Financial Statements

for the Period Ended 15 April 2025

3. Intangible Assets

Total
Cost £
At 16 April 2024 20,286
Revaluations (1,076)
At 15 April 2025 19,210
Amortisation
At 16 April 2024 0
At 15 April 2025 0
Net book value
At 15 April 2025 19,210
At 15 April 2024 20,286

INTRA-LABORATORIES LTD

Notes to the Financial Statements

for the Period Ended 15 April 2025

4. Tangible Assets

Total
Cost £
At 16 April 2024 3,283
At 15 April 2025 3,283
Depreciation
At 16 April 2024 0
Charge for year 220
At 15 April 2025 220
Net book value
At 15 April 2025 3,063
At 15 April 2024 3,283